NIDA Funding Strategy for Fiscal Year 2016

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

Mission

The National Institute on Drug Abuse (NIDA) is the lead federal agency supporting scientific research on drug use and its consequences. Our mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health through:

  • Strategically supporting and conducting basic and clinical research on drug use, its consequences, and the underlying neurobiological, behavioral, and social mechanisms involved.
  • Ensuring the effective translation, implementation, and dissemination of scientific research findings to improve the prevention and treatment of substance use disorders and enhance public awareness of addiction as a brain disorder.

Funding Strategy

Funding decisions will be based primarily on the programmatic priorities of the Institute and scientific merit of the application.  NIDA continues to give additional consideration to New Investigators and Early Stage Investigators (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-013.html, http://grants.nih.gov/grants/new_investigators/index.htm).

Information regarding FY 2016 NIH Extramural Financial Operations can be found at:

NIDA has established the following funding policy for FY 2016. 

Competing Awards:

NIDA may reduce competing awards from the IRG recommended levels in order to increase the number of awards issued. 

  • New and competing awards will be funded at approximately the same average cost as FY 15.
  • In general renewal grants should not increase by more than 10% over the prior year’s award.

Non-Competing Continuations Awards:

Consistent with overall NIH policy:

  • Non-competing continuation awards for RPGs and Centers will be funded at 99% of committed levels.
  • FY 2016 awards that have already been issued at 90% of committed level will be revised to adjust the award level.
  • Future year commitments will remain unchanged.
  • Ruth L. Kirschstein National Research Service Awards (NRSA) (Fs and Ts) will be funded with 2% stipend increases.  Those amounts for tuition do not change but the Training Related Expenses and the Institutional Allowance for postdoctoral trainees and fellows are increased by $1,000 with the implementation of the FY 2016 budget in accordance with recommendations in the Biomedical Workforce Task Force Report.